Stay updated with breaking news from Medanta institute. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tocilizumab cuts mortality risk in severely ill COVID-19 patients finds new trial conducted in India eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Arthritis drug Tocilizumab cuts death risk in severe COVID patients sentinelassam.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sentinelassam.com Daily Mail and Mail on Sunday newspapers.
Arthritis drug tocilizumab has been found to reduce the risk of death among patients with severe Covid-19 in a phase 3 trial conducted in India.However, the findings, published in the journal The Lancet Respiratory Medicine, does not support . ....
Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.